C-Rad AB (CRADb)

Currency in SEK
23.80
0.00(0.00%)
Closed·
Advertisement
CRADb is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
23.4024.00
52 wk Range
18.8539.40
Key Statistics
Prev. Close
23.8
Open
23.6
Day's Range
23.4-24
52 wk Range
18.85-39.4
Volume
38.06K
Average Volume (3m)
45.44K
1-Year Change
-27.6596%
Book Value / Share
11.08
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CRADb Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
35.00
Upside
+47.06%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

C-Rad AB News & Analysis

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 35.00
(+47.06% Upside)

C-Rad AB Earnings Call Summary for Q3/2026

  • C-RAD Q3 2026 order intake fell 29% YoY to 76M SEK, revenue dropped 24% to 85M SEK; shares plunged 26.13% to $21.20 in pre-market trading.
  • Company wrote down 93M SEK of backlog after reviewing older orders; EBIT margin of 12% significantly below 25% target amid execution challenges.
  • EMEA region weakest with order intake down 40%, revenue down 23%; Americas showed 20%+ order growth but revenue still declined 6% on timing issues.
  • Gross margin improved to 76% from 74% driven by record service revenue of 30M SEK; cash balance strengthened to 144M SEK with minimal debt levels.
  • No specific guidance provided; management cited multi-year transformation plan with new products expected in 2027 to support platform strategy shift.
Last Updated: 22/10/2026, 10:42
Read Full Transcript

Earnings

Latest Release
22/10/2026
EPS / Forecast
0.31 / 0.30
Revenue / Forecast
85.4M / 103M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.41
Dividend Yield
0.42%
Industry Median 1.58%
Annualised payout
0.10
Paid annually
5-Years Growth
-
Growth Streak

C-Rad (CRADb) Income Statement & Profits

Compare CRADb to Peers and Sector

Metrics to compare
CRADb
Peers
Sector
Relationship
P/E Ratio
16.9x−5.2x−0.2x
PEG Ratio
0.160.190.00
Price/Book
2.1x2.5x2.6x
Price / LTM Sales
1.9x3.3x2.8x
Upside (Analyst Target)
47.1%0.0%62.7%
Fair Value Upside
Unlock41.2%8.0%Unlock

C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Catalyst+ HD, a patient positioning, intra-fraction motion management, and respiratory gating solution for conventional and stereotactic treatment delivery; Catalyst+, a solution for patient set up and intra-fraction breath hold reproducibility; Catalyst+ PT, a surface image guided radiation therapy solution that supports proton therapy from simulation to treatment; Catalyst+ HD Ring Gantry solution for patient positioning, real-time motion monitoring, and respiratory gating; and Sentinel 4DCT, a laser-based optical surface scanning system. It also provides Catalyst, a 4D surface guided radiation therapy (SGRT) solution; Catalyst HD, a SGRT solution on stereotactic radiation therapy for online patient tracking before and during treatment delivery; and visual coaching solutions used for prospective and retrospective radiotherapy. In addition, the company offers cAutoVerify, an automation solution for the imaging suite and treatment room, automating patient identity validation, and accessory tracking. Further, it provides HIT1, HIT3, and HIT5 patient positioning laser, as well as laser positioning products and solutions. Additionally, the company offers support and training services; and service contracts. C-Rad AB (publ) was incorporated in 2004 and is headquartered in Uppsala, Sweden.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.02M3.01%23.92M
Other Institutional Investors
15.59M46.17%366.40M
Public Companies & Retail Investors
17.16M50.81%403.20M
Total
33.77M100.00%793.52M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Svea Bank AB (publ)11.92%4,024,96994,587
Linc AB11.23%3,792,42089,122

People Also Watch

167.80
OEMb
-1.53%
56.80
ENGCONb
-1.90%
95.60
APOTEA
+1.43%
64.10
ITECH
+0.16%
74.20
HEM
+4.51%

FAQ

What Is the C-Rad (Stockholm: CRADb) Share Price Today?

The C-Rad stock price today is 23.80 SEK.

What Stock Exchange Does C-Rad (CRADb) Trade On?

C-Rad is listed and trades on the Stockholm Stock Exchange.

What Is the Ticker (Stock Symbol) for C-Rad?

The stock symbol (also called a 'ticker') for C-Rad is "CRADb."

Does C-Rad Pay Dividends? What’s The Current CRADb Dividend Yield?

Yes, CRADb Pays Dividends to its Shareholders. The current C-Rad dividend yield is 0.4%%.

What Is the Current C-Rad Market Capitalisation?

As of today, C-Rad (Stockholm: CRADb) market cap is 803.65M SEK.

What Is C-Rad's (CRADb) Earnings Per Share (TTM)?

The C-Rad EPS is currently 1.41 (Trailing Twelve Months).

When Is the Next C-Rad Earnings Date?

C-Rad's next earnings report will be released on 11/02/2027.

Is CRADb a Buy or Sell From a Technical Analyst Perspective?

Based on today's C-Rad moving averages and other technical indicators, the daily buy/sell signal for CRADb stock is Strong Sell.

How Many Times Has C-Rad Stock Split?

C-Rad has split 3 times. (See the CRADb stock split history page for full effective split date and price information.)

How Many Employees Does C-Rad Have?

C-Rad has 98 employees, based on their latest Companies House report.

What is the current trading status of C-Rad (Stockholm: CRADb)?

As of 05/11/2026, C-Rad (CRADb) is trading at a share price of 23.80 SEK, with a previous close of 23.80 SEK. The stock has fluctuated within a day range of 23.40 SEK to 24.00 SEK, while its 52-week range spans from 18.85 SEK to 39.40 SEK.

What Is C-Rad (CRADb) Price Target According to Analysts?

The average 12-month price target for C-Rad is 35.00 SEK, with a high estimate of 35 SEK and a low estimate of 35 SEK. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +47.06% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.